TGFB1 and amyotrophic lateral sclerosis: In ALS patients, elevated TGF-β1 levels in serum, along with a trend towards increased TGF-β1 in spinal cord tissues, have been associated with a potential anti-inflammatory protective effect in the early stages of the disease, and with a neurotoxic effect in later disease [65].